Holger Monenschein - Concepedia

Author

Holger Monenschein

Amgen (United States)

Also Known As

H. MONENSCHEIN, H. Monenschein, Holger Monenschein, Monenschein, H., Monenschein, Holger, Nidhi Kaushal

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Clausthal University of Technology Takeda (United States)University of California San Diego Scripps Research Institute

About

Holger Monenschein is an author at Amgen (United States) specializing in engineering, organic chemistry, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	10	708
2	Medicine	8	8	242
3	Natural Sciences	6	6	131
4	Biochemistry	6	6	138
5	Biomolecular Engineering	6	6	183

Holger Monenschein

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Functionalized Polymers-Emerging Versatile Tools for Solution-Phase Chemistry and Automated Parallel Synthesis Andreas Kirschning, Holger Monenschein, Rüdiger Wittenberg Angewandte Chemie International Edition New TechnologiesEngineeringOrganic ChemistryChemistryPolymers	2001	377
Total Synthesis of Apoptolidin: Construction of Enantiomerically Pure Fragments K. C. Nicolaou, Konstantina C. Fylaktakidou, Holger Monenschein, Journal of the American Chemical Society	2003	116
Total Synthesis of Apoptolidin: Completion of the Synthesis and Analogue Synthesis and Evaluation K. C. Nicolaou, Yiwei Li, Kazuyuki Sugita, Journal of the American Chemical Society	2003	96
Preparation of Novel Haloazide Equivalents by Iodine(III)-Promoted Oxidation of Halide Anions Andreas Kirschning, MA Hashem, Holger Monenschein, The Journal of Organic Chemistry Chemical EngineeringEngineeringAltmetric Attention ScoreOrganic ChemistrySocial Media Presence	1999	75
Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid Matthew M. Weiss, Toni Williamson, Safura Babu‐Khan, Journal of Medicinal Chemistry	2012	63
Discovery of TRPM8 Antagonist (<i>S</i>)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine Daniel B. Horne, Kaustav Biswas, James Brown, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryTrpm8 AntagonistCluster HeadacheAmg 333	2018	60
Reactions of Alkenes, Alkynes, and Alkoxyallenes with New Polymer-Supported Electrophilic Reagents Holger Monenschein, Georgia Sourkouni‐Argirusi, Katherine M. Schubothe, Organic Letters Terminal AlkynesChemical EngineeringEngineeringAlkene MetathesisValuable 1-Iodo-alkynes	1999	54
The “Resin-Capture-Release” Hybrid Technique: A Merger between Solid- and Solution-Phase Synthesis Andreas Kirschning, Holger Monenschein, Rüdiger Wittenberg Chemistry - A European Journal Materials SciencePolymer-assisted Organic SynthesisChemical EngineeringEngineeringSimultaneous Release	2000	51
Studies Towards the Synthesis of Azadirachtin: Enantioselective Entry into the Azadirachtin Framework through Cascade Reactions K. C. Nicolaou, A. J. Roecker, Holger Monenschein, Angewandte Chemie International Edition	2003	48
Application of polymer-supported electrophilic reagents for the 1,2-functionalization of glycals Andreas Kirschning, Martin Jesberger, Holger Monenschein Tetrahedron Letters Biofunctional MaterialEngineeringPolymer-supported Electrophilic ReagentsGlycobiologyChemistry	1999	46

Page 1